No serious injuries related to the medication mix-up have been reported
In children with ASD, ADHD, sleep problems partially mediate the association between symptoms and communication
No significant changes seen in new prescriptions for antidepressants, benzodiazepines, or buprenorphine for opioid use disorder
Findings show dose-response relationship, with highest risk for autism, intellectual disability, tic disorder, depression, biopolar disorder
Youth with ADHD have increased rates of physical conditions such as asthma and eczema before diagnosis
4 percent increase in risk for CVD seen in association with each one-year increase in ADHD meds across 14 years of follow-up
Findings based on nearly four years of data with in-vehicle recording devices
Solriamfetol found to be well tolerated with no significant effect on mean heart rate, systolic or diastolic BP
Presence of adult ADHD significantly linked to increased dementia risk in unadjusted and adjusted analyses
Significant variance seen by sociodemographic factors